Biosensors International Group appoints Jeffrey Bryan Jump as Alternate Director

The Board believes that Mr. Jump has made invaluable contributions to the Company as Executive Director over the past years.

The Board of Biosensors International Group announced the appointment of Jeffrey Bryan Jump as Alternate Director Dr. Jack Wang, Chief Executive Officer of the Company effective 26 July 2012. 

Mr Jump, 53, is also President of Cardiovascular Business Unit, according to a Biosensors International Group report. 

Mr. Jump has over 30 years experience in the medical device industry. He joined Biosensors in 2003 as the Company’s subsidiary, Occam International B.V. in The Netherlands and soon afterwards became the Managing Director of Biosensors Europe SA. In 2005, he was additionally appointed Senior Vice President – Sales and Marketing, with responsibility for sales, sales support and global marketing for Europe, Middle East, Africa, India, North and South America. In 2007, he was also given global responsibility for clinical and regulatory activities. In July 2010, Mr. Jump became President and CEO, and subsequently co-CEO, a position he held until March 2012 when he was appointed as President of Biosensors’ newly-created Cardiovascular Business Unit.

Prior to joining Biosensors, Mr. Jump served as CEO of Xitact Medical Simulation which was acquired by Mentice. He has served as a board member with several start-up medical device companies, and currently is on the board of BeneChill Inc, PneumRx Inc and Veryan Medical. He has also served on the senior management team of several medical device companies, including Embol-X Inc., Alliance Medical Technologies, Cardio Thoracic Systems (CTS), Haemonetics S.A. and Pfizer Hospital products Group.

Mr. Jump received his Bachelor of Science degree from Indiana University, a graduate degree in Management Research from the University of South Australia and a Masters degree (Msc) from London Business School.